Filing Details

Accession Number:
0000908662-13-000304
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-06 18:20:57
Reporting Period:
2013-12-06
Filing Date:
2013-12-06
Accepted Time:
2013-12-06 18:20:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1177648 Enanta Pharmaceuticals Inc ENTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1572051 E. Marc Goldberg C/O Enanta Pharmaceuticals, Inc.
500 Arsenal Street
Watertown MA 02472
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-06 6,861 $27.93 547,606 No 4 S Indirect By BioVentures Investors Limited Partnership II
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By BioVentures Investors Limited Partnership II
Footnotes
  1. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.90 to $27.97, inclusive. The reporting person undertakes to provide to Enanta Pharmaceuticals, Inc., any security holder of Enanta Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
  2. These shares are held by BioVentures Investors Limited Partnership II, and are shares for which Mr. Goldberg may be deemed to share voting and investment control. Mr. Goldberg disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.